Picture of Shockwave Medical logo

SWAV — Shockwave Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Shockwave Medical Inc expected to post earnings of 81  cents a share - Earnings Preview

* Shockwave Medical Inc  SWAV.OQ   SWAV.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 8. 
    * The Santa Clara California-based  company is expected to
report 
a 57.3% increase in revenue to $147.31 million from $93.63
million a year ago, according to the mean estimate from 8
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Shockwave Medical
Inc is
for earnings of 81 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Shockwave
Medical
Inc is $280​, below​ its last closing price of $288.28. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  1.01        1.01       1.18      Beat    17.4
 Sep. 30 2022  0.67        0.67       0.92      Beat    37.6
 Jun. 30 2022  0.44        0.44       0.68      Beat    54.5​
 Mar. 31 2022  0.18        0.18       0.39      Beat    111.6
 ​​Dec.        0.11        0.09       0.34      Beat    300
 31 2021                                                
 Sep. 30 2021  -0.05       -0.06      0.05      Beat    187.5​
 Jun. 30 2021  -0.37       -0.40      -0.01     Beat    97.5
 Mar. 31 2021  -0.46       -0.45      -0.68     Missed  -52.2
 This summary was machine generated May 5 at 22:14 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Shockwave Medical

See all news